Corinne Menn, DOMenopause and survivorship care

Hormone Therapy for Menopause: What the Evidence Says Now

Headlines from 2002 still shape how many women feel about hormone therapy. Two decades of follow-up have given a clearer, more nuanced picture.

Hormone therapy7 min readPublished Reviewed

Key takeaways

  • Benefits and risks of hormone therapy depend heavily on age, time since menopause, type, dose and route.
  • For healthy women under 60 or within 10 years of menopause, benefits usually outweigh risks for bothersome symptoms.
  • Long-term Women's Health Initiative follow-up found no increase in deaths from any cause.
  • Women with early or surgical menopause often need hormone therapy at least until the average age of menopause.

Few medical topics have whiplashed women as much as menopausal hormone therapy. In the 1990s it was widely prescribed. In 2002, early results from the Women's Health Initiative (WHI) made headlines, and many women stopped overnight. Since then, researchers have spent two decades working out what those results did and did not mean.

What happened in 2002

The WHI hormone trials enrolled postmenopausal women with an average age of 63, many of them well past the menopause transition. The estrogen-plus-progestin trial was stopped early after higher rates of breast cancer, heart events, stroke and blood clots were seen in the hormone group. Use of hormone therapy fell sharply around the world.

What got less attention was that most women in the trial were older than the women who usually seek treatment for hot flashes, and that risks and benefits differed by age.

What longer follow-up showed

In 2017, WHI investigators reported on women followed for a median of about 18 years. Deaths from any cause were essentially the same in the hormone and placebo groups: 27.1% compared with 27.6%.[1] Hormone therapy did not increase or decrease the overall risk of dying over that time.

That finding doesn't make hormone therapy risk-free. It shows that the risks are specific and measurable, and that they depend on who is taking it, when, and in what form.

Current guidance, in brief

The Menopause Society's 2022 position statement sets out the current consensus.[2]

  • Timing matters. For women younger than 60 or within 10 years of menopause who have no contraindications, the benefit-risk balance is favorable for treating bothersome hot flashes and preventing bone loss.
  • Starting later is different. For women who start more than 10 years after menopause or after 60, the balance appears less favorable because absolute risks of heart disease, stroke, blood clots and dementia are higher.
  • The uterus needs protection. Women who still have a uterus take a progestogen with estrogen to protect the uterine lining.
  • Dose and route matter. The lowest effective dose is the goal, and how it's taken (pill, patch, gel) changes the risk profile.
  • No automatic stop date. Longer use is reasonable for documented reasons, such as persistent hot flashes, with shared decision-making and regular review.

Early, premature and surgical menopause

Women who reach menopause before 40, or before 45, lose estrogen's protection for bones and heart years earlier than average. Unless there's a reason not to, hormone therapy is generally advised at least until the average age of natural menopause.[3]

This matters for BRCA carriers who have their ovaries and tubes removed to lower cancer risk. ACOG advises offering hormone therapy after this surgery to women who have not had breast cancer, noting that limited data suggest short-term use does not meaningfully reduce the surgery's protective benefit.[4]

When systemic hormone therapy is usually not used

Examples include a history of breast cancer or another estrogen-sensitive cancer, a prior blood clot or stroke, active liver disease, coronary heart disease, and unexplained vaginal bleeding. This is not a complete list, and some situations are gray areas that need individual discussion. For many women in these groups, nonhormone treatments are effective alternatives.

Making the decision together

A good hormone therapy conversation covers your symptoms and how much they affect you, your personal and family history, your risk of heart disease, breast cancer and osteoporosis, and your own preferences. The goal isn't to talk you into or out of anything. It's to give you accurate numbers in context, so the choice you make is your own.

It's also a decision you can revisit. Many women start at a low dose, check in after a few months, and adjust. If symptoms change, if a new diagnosis comes up, or if you simply want to try stopping, the conversation reopens. Stopping is usually done gradually or simply, depending on what you're taking, and some women find their symptoms return. Neither choice is permanent, and neither is a failure.

When to see a doctor

Talk with a clinician before starting or stopping hormone therapy. Get prompt care for unexpected vaginal bleeding, a new breast lump, leg swelling or pain, or sudden shortness of breath. Call 911 for chest pain or signs of stroke.

Sources

  1. Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials. JAMA. 2017;318(10):927-938. View source (opens in a new tab)
  2. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. View source (opens in a new tab)
  3. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28(9):973-997. View source (opens in a new tab)
  4. American College of Obstetricians and Gynecologists. Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 182. Obstet Gynecol. 2017;130(3):e110-e126. View source (opens in a new tab)

Corinne Menn, DO, FACOG, MSCP

Board-certified OB/GYN and Menopause Society Certified Practitioner. Breast cancer survivor of more than 20 years and BRCA carrier.

About Dr. Menn  Editorial policy

This article is general education for adults and is not a substitute for personal medical advice. If you have a medical emergency, call 911.

Related articles